These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25075844)

  • 1. Mutant ADA2 in vasculopathies.
    Kastner DL; Zhou Q; Aksentijevich I
    N Engl J Med; 2014 Jul; 371(5):480-1. PubMed ID: 25075844
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutant ADA2 in vasculopathies.
    Segel R; King MC; Levy-Lahad E
    N Engl J Med; 2014 Jul; 371(5):481. PubMed ID: 25083540
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutant ADA2 in vasculopathies.
    Van Eyck L; Liston A; Wouters C
    N Engl J Med; 2014 Jul; 371(5):480. PubMed ID: 25075848
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutant ADA2 in vasculopathies.
    Bras J; Guerreiro R; Santo GC
    N Engl J Med; 2014 Jul; 371(5):478-80. PubMed ID: 25075847
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutant ADA2 in vasculopathies.
    Van Eyck L; Liston A; Meyts I
    N Engl J Med; 2014 Jul; 371(5):478-9. PubMed ID: 25075846
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutant ADA2 in vasculopathies.
    van Montfrans J; Zavialov A; Zhou Q
    N Engl J Med; 2014 Jul; 371(5):478. PubMed ID: 25075845
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasculitis syndromes: New insights into the molecular basis of systemic vasculitis.
    Cid MC; Aróstegui JI
    Nat Rev Rheumatol; 2014 Jun; 10(6):323-4. PubMed ID: 24818673
    [No Abstract]   [Full Text] [Related]  

  • 8. Early-onset stroke and vasculopathy associated with mutations in ADA2.
    Zhou Q; Yang D; Ombrello AK; Zavialov AV; Toro C; Zavialov AV; Stone DL; Chae JJ; Rosenzweig SD; Bishop K; Barron KS; Kuehn HS; Hoffmann P; Negro A; Tsai WL; Cowen EW; Pei W; Milner JD; Silvin C; Heller T; Chin DT; Patronas NJ; Barber JS; Lee CC; Wood GM; Ling A; Kelly SJ; Kleiner DE; Mullikin JC; Ganson NJ; Kong HH; Hambleton S; Candotti F; Quezado MM; Calvo KR; Alao H; Barham BK; Jones A; Meschia JF; Worrall BB; Kasner SE; Rich SS; Goldbach-Mansky R; Abinun M; Chalom E; Gotte AC; Punaro M; Pascual V; Verbsky JW; Torgerson TR; Singer NG; Gershon TR; Ozen S; Karadag O; Fleisher TA; Remmers EF; Burgess SM; Moir SL; Gadina M; Sood R; Hershfield MS; Boehm M; Kastner DL; Aksentijevich I
    N Engl J Med; 2014 Mar; 370(10):911-20. PubMed ID: 24552284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation.
    Lamprecht P; Humrich JY; Diebold I; Riemekasten G
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):177. PubMed ID: 29600946
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy.
    Garg N; Kasapcopur O; Foster J; Barut K; Tekin A; Kızılkılıç O; Tekin M
    Eur J Pediatr; 2014 Jun; 173(6):827-30. PubMed ID: 24737293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
    Caorsi R; Penco F; Grossi A; Insalaco A; Omenetti A; Alessio M; Conti G; Marchetti F; Picco P; Tommasini A; Martino S; Malattia C; Gallizzi R; Podda RA; Salis A; Falcini F; Schena F; Garbarino F; Morreale A; Pardeo M; Ventrici C; Passarelli C; Zhou Q; Severino M; Gandolfo C; Damonte G; Martini A; Ravelli A; Aksentijevich I; Ceccherini I; Gattorno M
    Ann Rheum Dis; 2017 Oct; 76(10):1648-1656. PubMed ID: 28522451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
    Human A; Pagnoux C
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histiocytoid Sweet Syndrome Presenting in Two Sisters With Deficiency of Deaminase Type 2.
    Hui Ong EL; Cooray S; Brogan P; Calonje E
    Am J Dermatopathol; 2023 Jan; 45(1):47-50. PubMed ID: 36484606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel compound heterozygous variants in CECR1 gene associated with childhood onset polyarteritis nodosa and deficiency of ADA2.
    Keer N; Hershfield M; Caskey T; Unizony S
    Rheumatology (Oxford); 2016 Jun; 55(6):1145-7. PubMed ID: 27069017
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
    Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
    Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological dermatological features of deficiency of adenosine deaminase 2: A multicenter, retrospective, observational study.
    Chasset F; Fayand A; Moguelet P; Kouby F; Bonhomme A; Franck N; Goldman-Lévy G; Fraitag S; Barbaud A; Queyrel V; Touitou I; Boursier G; Sarrabay G; Ducharme-Benard S; Dupin N; Francès C; Bessis D; Georgin-Lavialle S;
    J Am Acad Dermatol; 2020 Dec; 83(6):1794-1798. PubMed ID: 32283244
    [No Abstract]   [Full Text] [Related]  

  • 17. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.
    Schnappauf O; Sampaio Moura N; Aksentijevich I; Stoffels M; Ombrello AK; Hoffmann P; Barron K; Remmers EF; Hershfield M; Kelly SJ; ; Cuthbertson D; Carette S; Chung SA; Forbess L; Khalidi NA; Koening CL; Langford CA; McAlear CA; Monach PA; Moreland L; Pagnoux C; Seo P; Springer JM; Sreih AG; Warrington KJ; Ytterberg SR; Kastner DL; Grayson PC; Merkel PA;
    Arthritis Rheumatol; 2021 Mar; 73(3):512-519. PubMed ID: 33021335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
    Navon Elkan P; Pierce SB; Segel R; Walsh T; Barash J; Padeh S; Zlotogorski A; Berkun Y; Press JJ; Mukamel M; Voth I; Hashkes PJ; Harel L; Hoffer V; Ling E; Yalcinkaya F; Kasapcopur O; Lee MK; Klevit RE; Renbaum P; Weinberg-Shukron A; Sener EF; Schormair B; Zeligson S; Marek-Yagel D; Strom TM; Shohat M; Singer A; Rubinow A; Pras E; Winkelmann J; Tekin M; Anikster Y; King MC; Levy-Lahad E
    N Engl J Med; 2014 Mar; 370(10):921-31. PubMed ID: 24552285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of adenosine deaminase 2 gene variants in pediatric deficiency of adenosine deaminase 2: A structural biological approach.
    Zervou MI; Goulielmos GN; Matalliotakis M; Matalliotaki C; Spandidos DA; Eliopoulos E
    Mol Med Rep; 2020 Feb; 21(2):876-882. PubMed ID: 31974608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.